Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 30,000 shares at $20.26 ($608K) on 2026-08-13, disclosed to the SEC on 2026-08-14.
Scheduled sale ($608k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |
| CGEM | SELL | 2026-02-26 | $25K | — | Filing → |